Clinical trial
Amiodarone to Prevent Post-Operative Arrhythmias
NCT00251706 · University of Calgary, Other · Completed
Key facts
| NCT number | NCT00251706 |
|---|---|
| Title | Amiodarone to Prevent Post-Operative Arrhythmias |
| Official title | Prophylactic Amiodarone for the Prevention of Arrhythmias That Begin Early After Revascularization, Valve Replacement, or Repair - PAPABEAR |
| Lead sponsor | University of Calgary, Other |
| Collaborators | Heart and Stroke Foundation of Canada Wyeth is now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | amiodarone |
| Enrollment | 600 |
| Start date | Feb 1, 1999 |
| Completion | Sep 1, 2004 |
| First posted | Nov 10, 2005 |
| Last update posted | May 5, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: